Page 5 - Ohnson Johnson News Today

Sen. Bernie Sanders (I-Vt.), chair of the Senate Committee on Health, Education, Labor and Pensions (HELP), announced Thursday he will be holding a vote to issue subpoenas to the CEOs of Johnson & Johnson and Merck for testimonies on drug pricing after they refused requests to appear before the Senate panel. The subpoenas for Johnson…

Berkshire Hathaway exited its positions in these two blue chip dividend stocks last year, but they are still superb buys for certain types of investors.

Among the Dow Jones Industrial Average's 30 time-tested components, there are two that are historically cheap and ripe for the picking, while another outperformer is riddled with issues.

The acquisition will add a promising cancer therapy for J&J, which is paying a 105% premium, and move it further into a hot space for drugmakers.

J&J will pay $28 per share of Ambrx, which represents a premium of about 105% to the stock's last close. Ambrx is developing therapies that belong to the class of drugs called antibody drug conjugates (ADC), which are described by researchers as "guided missiles" to target cancer cells and minimize damage to healthy tissue. The deal would help J&J add a promising therapy for cancer and move further into a hot space for drugmakers that has witnessed a rush of deals in r...

The settlement would avert potential lawsuits alleging J&J hid any links between the talc in its powder and various cancers, the report said citing people familiar with the deal. J&J and representatives for state attorneys general are still working out the specific terms of the deal but have agreed on the total amount, Bloomberg News reported. J&J did not immediately respond to a Reuters request for comment.

Novartis is poised to prevail in the auction for Cytokinetics, ahead of other bidders that include AstraZeneca and Johnson & Johnson, according to the source. A deal could be announced as early as this week, the source said, helping Novartis gain access to Cytokinetics' experimental treatment, aficamten, for hypertrophic cardiomyopathy (HCM), an inherited chronic heart disease that can cause cardiac arrest.

Better sober living homes, mid-Cape detox center, basic needs fulfilled: a wish list for how Cape towns could spend $8.3M in opioid settlement.

A modest amount of money can go a long way when it's put to work in industry-leading, time-tested businesses with well-defined catalysts.

These companies need no introduction.